lorazepam and olanzapine

lorazepam has been researched along with olanzapine in 50 studies

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.00)18.2507
2000's24 (48.00)29.6817
2010's20 (40.00)24.3611
2020's5 (10.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Chang, TK; Ensom, MH; Kiang, TK1
Abraham, MH; Acree, WE; Ibrahim, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hillard, JR1
Breier, A; David, S; Janicak, P; Koch, M; Meehan, K; Rizk, R; Small, J; Tohen, M; Tran, P; Walker, D; Zhang, F1
Beasley, CM; Beckett, LM; Breier, A; David, SR; Feldman, PD; Jones, B; Meehan, KM; Mintzer, JE; Nisivoccia, JR; Wang, H1
Garlipp, P; Machleidt, W1
Cherkerzian, S; Cohen, BM; Lange, N; Ma, J; Wager, C; Ye, N1
Alaka, K; Battaglia, J; Lindborg, SR; Meehan, K; Wright, P1
Ahl, J; Kinon, BJ; McMullen, E; Rotelli, MD1
Glick, ID; Romano, SJ; Simpson, GM; Siu, CO; Weiden, PJ1
Belgamwar, RB; Fenton, M1
Carnahan, RM; Perry, PJ1
Roche-Desilets, J; Zacher, JL1
D'Souza, DC; Lee, TS; Rohrbaugh, RM; Srihari, VH1
Chandrasekaran, R; Madugula, A; Rakesh, G1
Hulstijn, W; Ruigt, GS; Sabbe, BG; Verkes, RJ; Wezenberg, E1
Athey, R; Forlano, R; Singh, D1
Chen, L; Kinon, BJ; Kollack-Walker, S; Sniadecki, J; Stauffer, VL1
Borkar, HA; Chandak, S; Srivastava, A1
Dadić-Hero, E; Medved, P; Petranović, D; Ruzić, K1
Alexander, J; Allen, MH; Huf, G; Raveendran, NS1
Hewer, W; Kauder, E; Vierling, P1
Adams, CE; Coutinho, ES; Huf, G1
Siman, E; Stewart, SL; Swart, GT1
Bak, M; Marcelis, M; van Os, J1
Burrows, D; Emmerson, B; Kingswell, B; Kubler, P; McMahon, K; Moudgil, V; Woodbridge, A1
Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F1
Aldana-Bernier, L; Bhojani, S; Pawelzik, T; Sikder, M1
Golla, H; Perrar, KM; Voltz, R1
Beck, A; Gillies, D; Rathbone, J; Sampson, S1
Dutta, A; Rana, S; Talukdar, A; Talukdar, P1
Carlo, S; Castaing-Lespier, PA; Sabaté, N; Santos-Cubiñá, J; Torres-Martin, A; Torres-Rodríguez, A1
Kenedi, C; West, S1
Junewar, V; Rathaur, BP; Verma, R1
Düring, S; Hansen, BS; Jørgensen, A; Jørgensen, MB; Kondziella, D; Pinborg, LH; Stanislaus, S1
Barnhorst, A; Xiong, GL1
Chen, HH; Chen, YH; Hsieh, MH; Huang, CL; Huang, GH; Hwang, TJ; Hwu, HG1
Ellini, S; Feki, I; Jamoussi, I; Masmoudi, J; Smaoui, N1
Hardman, MI; Sprung, J; Weingarten, TN1
Bak, E; Bak, M; Bervoets, C; Bienkowski, P; De Fruyt, J; Dom, G; Drukker, M; Fiorillo, A; Frydecka, D; Misiak, B; Preuss, WU; Samochowiec, A; Samochowiec, J; Sampogna, G; Weltens, I1
Garel, N; Joober, R1
Gropp, C; Jaworowski, S; Malka, M; Weiser, M1
Kollias, K; Mantonakis, L; Marouda, K1
Osser, DN; Stetson, SR1
Cui, Y; Ding, Y; Ji, M; Liu, Y; Wang, D; Wang, H; Yang, M; Zhang, H; Zhuang, T1
Akyuz, E; Das, A; Tiwari, S1

Reviews

13 review(s) available for lorazepam and olanzapine

ArticleYear
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Emergency treatment of acute psychosis.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 1

    Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Emergency Services, Psychiatric; Emergency Treatment; Haloperidol; History, 20th Century; Humans; Lorazepam; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone

1998
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses.
    The Cochrane database of systematic reviews, 2005, Apr-18, Issue:2

    Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Olanzapine; Psychotic Disorders; Randomized Controlled Trials as Topic

2005
Haloperidol plus promethazine for psychosis-induced aggression.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic

2009
[Haloperidol plus promethazine for agitated patients--a systematic review].
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2009, Volume: 31, Issue:3

    Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Randomized Controlled Trials as Topic

2009
[Rapid tranquillisation; review of the literature and recommendations].
    Tijdschrift voor psychiatrie, 2011, Volume: 53, Issue:10

    Topics: Aggression; Benzodiazepines; Conscious Sedation; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Midazolam; Olanzapine; Practice Guidelines as Topic; Promethazine; Psychotic Disorders; Time Factors; Treatment Outcome

2011
[Pharmacological treatment of delirium in palliative care patients. A systematic literature review].
    Schmerz (Berlin, Germany), 2013, Volume: 27, Issue:2

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Delirium; Evidence-Based Medicine; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Olanzapine; Palliative Care; Piperazines; Quinolones; Risk Factors

2013
Benzodiazepines for psychosis-induced aggression or agitation.
    The Cochrane database of systematic reviews, 2013, Apr-30, Issue:4

    Topics: Acute Disease; Aggression; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Emergency Treatment; Haloperidol; Humans; Lorazepam; Olanzapine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic

2013
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
    Current opinion in organ transplantation, 2014, Volume: 19, Issue:2

    Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Lithium Compounds; Lorazepam; Methylprednisolone; Olanzapine; Polyarteritis Nodosa; Prednisone; Psychoses, Substance-Induced

2014
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
    Bosnian journal of basic medical sciences, 2019, May-20, Volume: 19, Issue:2

    Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult

2019
The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.
    European psychiatry : the journal of the Association of European Psychiatrists, 2019, Volume: 57

    Topics: Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Psychotic Disorders; Treatment Outcome

2019
Psychopharmacology of agitation in acute psychotic and manic episodes.
    Current opinion in psychiatry, 2022, 05-01, Volume: 35, Issue:3

    Topics: Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Mania; Olanzapine; Promethazine; Psychomotor Agitation; Psychopharmacology; Psychotic Disorders

2022

Trials

8 trial(s) available for lorazepam and olanzapine

ArticleYear
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:4

    Topics: Adult; Affect; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cholinergic Antagonists; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychomotor Agitation; Treatment Outcome

2001
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 26, Issue:4

    Topics: Acute Disease; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Dementia; Double-Blind Method; Female; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychomotor Agitation

2002
Calming versus sedative effects of intramuscular olanzapine in agitated patients.
    The American journal of emergency medicine, 2003, Volume: 21, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Double-Blind Method; Drug Administration Schedule; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Olanzapine; Pirenzepine; Psychomotor Agitation; Retrospective Studies; Schizophrenia; Treatment Outcome

2003
Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia.
    The American journal of emergency medicine, 2004, Volume: 22, Issue:3

    Topics: Acute Disease; Administration, Oral; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emergency Services, Psychiatric; Emergency Treatment; Female; Haloperidol; Humans; Lorazepam; Male; Olanzapine; Prospective Studies; Psychomotor Agitation; Schizophrenia; Severity of Illness Index; Treatment Outcome

2004
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    The American journal of psychiatry, 2004, Volume: 161, Issue:10

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain

2004
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:6

    Topics: Adult; Affect; Antipsychotic Agents; Arousal; Benzodiazepines; Choice Behavior; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Memory Disorders; Mianserin; Mirtazapine; Olanzapine; Psychological Tests; Psychomotor Performance; Reaction Time; Reference Values; Saccades; Surveys and Questionnaires; Verbal Learning

2007
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Dopamine Antagonists; Double-Blind Method; Female; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Triglycerides; United States; Young Adult

2008
Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:5

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Taiwan; Treatment Outcome

2015

Other Studies

29 other study(ies) available for lorazepam and olanzapine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
[Koro--discussing a transcultural psychopathological phenomenon].
    Fortschritte der Neurologie-Psychiatrie, 2003, Volume: 71, Issue:2

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Culture; Humans; Hypnotics and Sedatives; Koro; Lorazepam; Male; Olanzapine; Pirenzepine; Schizophrenic Psychology

2003
Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.
    Psychopharmacology, 2003, Volume: 167, Issue:4

    Topics: Amygdala; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Diphenhydramine; Haloperidol; Immunohistochemistry; Injections, Intraperitoneal; Lorazepam; Male; Midline Thalamic Nuclei; Nucleus Accumbens; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley

2003
Methodological concerns in a trial of ziprasidone and olanzapine.
    The American journal of psychiatry, 2005, Volume: 162, Issue:7

    Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Schizophrenia; Schizophrenic Psychology; Thiazoles

2005
Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12

    Topics: Antipsychotic Agents; Benzodiazepines; Drug Approval; Drug Interactions; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Hypotension; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Olanzapine; Schizophrenia, Paranoid; United States

2005
Revisiting cycloid psychosis: a case of an acute, transient and recurring psychotic disorder.
    Schizophrenia research, 2006, Feb-28, Volume: 82, Issue:2-3

    Topics: Acute Disease; Aged; Benzodiazepines; Cognition Disorders; Delusions; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Hallucinations; Hospitalization; Humans; Lorazepam; Male; Olanzapine; Psychomotor Agitation; Psychotic Disorders; Recurrence

2006
Homatropine and psychosis in Weill-Marchesani syndrome.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:7

    Topics: Abnormalities, Multiple; Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Eye Abnormalities; Hallucinations; Humans; Lorazepam; Male; Olanzapine; Syndrome; Trabeculectomy; Tropanes

2006
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
    The Australian and New Zealand journal of psychiatry, 2008, Volume: 42, Issue:6

    Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone

2008
Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:1

    Topics: Antipsychotic Agents; Benzodiazepines; Consciousness; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Schizophrenia, Paranoid; Tomography, X-Ray Computed

2009
Olanzapine monotherapy in a long-term treatment for schizophrenia: case study.
    Psychiatria Danubina, 2009, Volume: 21, Issue:1

    Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Humans; Long-Term Care; Lorazepam; Male; Middle Aged; Olanzapine; Schizophrenia, Paranoid; Treatment Outcome

2009
Fatal pulmonary embolism following antipsychotic treatment and physical restraint.
    Pharmacopsychiatry, 2009, Volume: 42, Issue:5

    Topics: Aged; Antipsychotic Agents; Benzodiazepines; Fatal Outcome; Female; Haloperidol; Heart Arrest; Heart Failure; Humans; Hypnotics and Sedatives; Lorazepam; Olanzapine; Practice Guidelines as Topic; Pulmonary Artery; Pulmonary Embolism; Restraint, Physical; Schizophrenia, Paranoid; Venous Thromboembolism

2009
The use of Pro Re Nata or Statim medications for behavioral control: a summary of experience at a tertiary care children's mental health center.
    Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:1

    Topics: Adolescent; Age Factors; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Child; Chlorpromazine; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Female; Humans; Intellectual Disability; Length of Stay; Lorazepam; Male; Mental Disorders; Mental Health Services; Olanzapine; Practice Patterns, Physicians'; Prospective Studies; Sex Factors

2011
A new clinical protocol for the pharmacological management of acute behavioural disturbance.
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2011, Volume: 19, Issue:5

    Topics: Administration, Oral; Antipsychotic Agents; Benzodiazepines; Clinical Protocols; Humans; Injections, Intramuscular; Lorazepam; Olanzapine; Psychomotor Agitation

2011
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    L'Encephale, 2013, Volume: 39 Suppl 1

    Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic

2013
Psychotic disorder after contact with a potentially rabid animal and post-exposure prophylactic anti-rabies treatment.
    Clinical schizophrenia & related psychoses, 2014, Volume: 8, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; Dibenzothiazepines; Female; Haloperidol; Humans; Lorazepam; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Rabies; Rabies Vaccines; Young Adult

2014
Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience.
    BMJ case reports, 2013, Jun-27, Volume: 2013

    Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Catatonia; Humans; Hypnotics and Sedatives; Lorazepam; Male; Olanzapine; Parkinsonian Disorders; Pramipexole; Typhoid Fever

2013
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report.
    Boletin de la Asociacion Medica de Puerto Rico, 2013, Volume: 105, Issue:3

    Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Carnitine; Citalopram; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Drug Substitution; Drug Therapy, Combination; Humans; Hyperammonemia; Ketoglutarate Dehydrogenase Complex; Lorazepam; Male; Mood Disorders; Olanzapine; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Valproic Acid

2013
An atypical case of neuroleptic malignant syndrome precipitated by valproate.
    BMJ case reports, 2014, Mar-06, Volume: 2014

    Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Levetiracetam; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Piracetam; Pramipexole; Psychotic Disorders; Valproic Acid

2014
Anti-N-methyl-D-aspartate receptor encephalitis is an important differential diagnosis in acute psychiatric disease.
    Acta psychiatrica Scandinavica, 2015, Volume: 131, Issue:1

    Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Anxiety Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antipsychotic Agents; Benzodiazepines; Cognitive Dysfunction; Diagnosis, Differential; Humans; Immunoglobulins; Lorazepam; Male; Mental Disorders; Olanzapine; Treatment Outcome; Young Adult

2015
Pulmonary embolism in a psychiatric patient.
    The American journal of psychiatry, 2014, Nov-01, Volume: 171, Issue:11

    Topics: Adult; Aggression; Antipsychotic Agents; Autopsy; Benzodiazepines; Bipolar Disorder; Catatonia; Death, Sudden; Female; Humans; Hypothyroidism; Incidence; Lorazepam; Obesity; Olanzapine; Ovarian Neoplasms; Patient Admission; Patient Transfer; Pulmonary Embolism; Restraint, Physical; Risk; Valproic Acid; Venous Thrombosis

2014
[Cushing's disease in a psychiatric setting].
    L'Encephale, 2017, Volume: 43, Issue:5

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Hypnotics and Sedatives; Lorazepam; Magnetic Resonance Imaging; Mental Disorders; Olanzapine; Pituitary ACTH Hypersecretion

2017
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
    Journal of psychiatry & neuroscience : JPN, 2019, Nov-01, Volume: 44, Issue:6

    Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Delusions; Dystonia; Female; Hallucinations; Humans; Hypnotics and Sedatives; Intellectual Disability; Lorazepam; Loxapine; Olanzapine; Paranoid Disorders; Psychotic Disorders; Quetiapine Fumarate; Tourette Syndrome

2019
Three Cases of COVID-19-related First Onset Brief Reactive Psychosis.
    The Israel Medical Association journal : IMAJ, 2020, Volume: 22, Issue:10

    Topics: Adult; Antipsychotic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Delusions; Haloperidol; Humans; Involuntary Treatment; Lorazepam; Male; Olanzapine; Pandemics; Paranoid Behavior; Pneumonia, Viral; Psychotic Disorders; SARS-CoV-2; Social Isolation; Treatment Outcome

2020
Brief psychotic disorder with delusion content related to the COVID-19 outbreak.
    Psychiatrike = Psychiatriki, 2021, Apr-19, Volume: 32, Issue:1

    Topics: Adult; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; COVID-19; Delusions; Humans; Involuntary Commitment; Life Change Events; Lorazepam; Male; Olanzapine; Pandemics; Psychomotor Agitation; Psychotic Disorders; Stress, Psychological

2021
Clinical significance of potential drug-drug interactions in older adults with psychiatric disorders: a retrospective study.
    BMC psychiatry, 2022, 08-22, Volume: 22, Issue:1

    Topics: Aged; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Lorazepam; Mental Disorders; Olanzapine; Quetiapine Fumarate; Retrospective Studies

2022
Recurrent Catatonia: Infection and Immunity in an Idiopathic Illness.
    Journal of psychiatric practice, 2023, 01-01, Volume: 29, Issue:1

    Topics: Adolescent; Catatonia; Encephalitis; Female; Humans; Lorazepam; Mental Disorders; Olanzapine

2023